Coronary disease & ACSRandomised controlled trial

Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study

CirculationPublished

  • Randomised controlled trial
  • multicentre
  • double-blind
  • placebo-controlled

Authors' conclusion

Physiological thresholds for angina, FFRangina and RFRangina, are highly individualized, vary with cardiac workload, and are consistently lower than the universal ischemia-based thresholds used to guide revascularization.

Study context

Population
Patients with stable angina and single-vessel CAD after imaging-guided percutaneous coronary intervention (PCI)
Participants
65 patients
Comparison
In-stent balloon inflation vs placebo inflation at rest and during low- and high-intensity exercise
Primary endpoint
FFRangina and RFRangina at symptom onset (physiological thresholds for angina)

Primary result

As reported in the abstract

Physiological thresholds for angina
GroupValueFFRanginaRFRangina
Restmedian 0.29 (IQR 0.23–0.35)0.29 (IQR, 0.23-0.35)0.22 (IQR, 0.16-0.30)
Low-intensity exercisemedian 0.38 (IQR 0.30–0.48)0.38 (IQR, 0.30-0.48)0.26 (IQR, 0.18-0.36)
High-intensity exercisemedian 0.45 (IQR 0.36–0.55)0.45 (IQR, 0.36-0.55)0.32 (IQR, 0.23-0.46)
All thresholds significantly lower than clinical diagnostic cut points
P < 0.001

Further findings

Pre-PCI physiology

Median pre-PCI fractional flow reserve (FFR)
0.59 (IQR, 0.46-0.70)
Median pre-PCI RFR
0.61 (IQR, 0.40-0.82)

Symptom reproducibility by threshold (rest, low-, high-intensity exercise)

Lower FFRangina associated with greater symptom reproducibility
P = 0.008, P<0.001, P<0.001
Lower RFRangina associated with greater symptom reproducibility
P = 0.015, P<0.001, P=0.002

Baseline angina burden and symptom relief with PCI

Lower angina thresholds predicted higher baseline angina burden and greater symptom relief with PCI
probability of interaction >0.999

Original publication

Determining the Physiological Threshold for Angina (ORBITA-FIRE): A Double-Blind, Randomized, Placebo-Controlled Study. Circulation. Published 8 May 2026. doi:10.1161/circulationaha.125.078738

Summarised from the published abstract; every number is checked against it